The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia: Randomised, Double-blind, Placebo-controlled Trial.

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01608750

Enrollment

200

Registered

2012-05-31

Start date

2012-06-30

Completion date

2013-06-30

Last updated

2012-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonulcer Dyspepsia

Brief summary

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

Interventions

DRUGPantoprazol

40mg/day, oral, 28 days

DRUGFolic Acid

5 mg/day, oral, 28 days

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* aged 18-45 years with symptoms of dyspepsia, * no evidence of organic disease.

Exclusion criteria

* Patients with alarm symptoms, * Severe concomitant illness, * Pregnancy or lactation, * Alcohol or drug abuse, * Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Design outcomes

Primary

Measure	Time frame
Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.	one year

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026